Financials data is unavailable for this security.
View more
Year on year BioRestorative Therapies Inc grew revenues 21.70% from 119.80k to 145.80k while net income improved from a loss of 18.49m to a smaller loss of 10.42m.
Gross margin | 79.04% |
---|---|
Net profit margin | -1,636.79% |
Operating margin | -3,205.76% |
Return on assets | -43.49% |
---|---|
Return on equity | -54.15% |
Return on investment | -53.99% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at BioRestorative Therapies Inc fell by 829.39k. However, Cash Flow from Investing totalled 3.25m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 6.43m for operations while cash generated from financing totalled 2.35m.
Cash flow per share | -0.868 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.44 |
---|---|
Tangible book value per share | 1.35 |
More ▼
Balance sheet in USDView more
Current ratio | 2.95 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼